SCHEMBL1060906

SCHEMBL1060906

O=C1CC=NC=N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL17894713 0.97
SCHEMBL1199564 0.68
SCHEMBL27923864 0.67
SCHEMBL27838224 0.67
SCHEMBL4316166 0.56
Hydrochloric Acid SCHEMBL2443920 0.54
Hydrochloric Acid SCHEMBL4762189 0.53
SCHEMBL27563889 0.53
SCHEMBL7491815 0.50
SCHEMBL4875489 0.50

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 111 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260007745-A1 ALDH Inhibitors to Promote Immune Cell Expansion UNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION (US) 2026-01-08 US claimed
EP-3612223-B1 TREATING MALE SENESCENCE NAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING (CN) 2024-07-31 EP claimed
WO-2023059884-A1 ALDH INHIBITORS TO PROMOTE IMMUNE CELL EXPANSION UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2023-04-13 WO claimed
CN-115362149-A SHP2 inhibitor and composition and application thereof 贝达药业股份有限公司 2022-11-18 CN claimed
EP-3302484-B1 6-ALKYL DIHYDROPYRAZOLOPYRIMIDINONE COMPOUNDS AS PDE2 INHIBITORS MERCK SHARP & DOHME (US) 2020-09-16 EP claimed
CN-108484614-B Pyrazolo [3,4-d ] pyrimidine-4 (5H) -ketone derivative and preparation method and application thereof 南开大学 2020-01-14 CN claimed
EP-3302486-A1 DIHYDROPYRAZOLOPYRIMIDINONE COMPOUNDS AS PDE2 INHIBITORS Merck Sharp & Dohme Corp. (US) 2018-04-11 EP claimed
EP-3302484-A1 6-ALKYL DIHYDROPYRAZOLOPYRIMIDINONE COMPOUNDS AS PDE2 INHIBITORS Merck Sharp & Dohme Corp. (US) 2018-04-11 EP claimed
WO-2016196071-A1 6-ALKYL DIHYDROPYRAZOLOPYRIMIDINONE COMPOUNDS AS PDE2 INHIBITORS MERCK SHARP & DOHME CORP. (US) 2016-12-08 WO claimed
WO-2016196417-A1 DIHYDROPYRAZOLOPYRIMIDINONE COMPOUNDS AS PDE2 INHIBITORS MERCK SHARP & DOHME CORP. (US) 2016-12-08 WO claimed
CN-104349778-A Composition for preventing vascular activity in the treatment of blood loss and anemia BLUMENSTEIN JAN 2015-02-11 CN claimed
CN-103797006-A 4-piperidinyl compounds useful as tankyrase inhibitors NOVARTIS AG 2014-05-14 CN claimed
CN-103619831-A Azole heterocyclic compound, preparation method, pharmaceutical composition and use SHANGHAI INST MATERIA MEDICA 2014-03-05 CN claimed
CN-103467471-A Organic compounds INTRA CELLULAR THERAPIES INC 2013-12-25 CN claimed
WO-2012074912-A1 METHODS, ASSAYS AND COMPOUNDS FOR TREATING BACTERIAL INFECTIONS BY INHIBITING METHYLTHIOINOSINE PHOSPHORYLASE ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY (US) 2012-06-07 WO claimed
WO-2008030119-A9 ACYCLIC AMINE INHIBITORS OF NUCLEOSIDE PHOSPHORYLASES AND HYDROLASES INDUSTRIAL RESEARCH LIMITED (NZ) 2009-09-24 WO claimed
WO-2009082247-A1 PROCESS FOR PREPARING IMMUCILLINS HAVING A METHYLENE LINK INDUSTRIAL RESEARCH LIMITED (NZ) 2009-07-02 WO claimed
US-20260125380-A1 PRMT5 INHIBITORS AND METHODS OF USE SHANGHAI APEIRON THERAPEUTICS COMPANY LIMITED (CN) 2026-05-07 US disclosed
WO-1999020251-A1 USE OF INHALED NO AS ANTI-INFLAMMATORY AGENT THE GENERAL HOSPITAL CORPORATION (US) 1999-04-29 WO disclosed
US-4189483-A FUNGICIDE, INSECTICIDES, BACTERICIDES, MITICIDES, FOR PLANTS IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) 1980-02-19 US disclosed